Nanhu Quan

Dr. Nanhu Quan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
YLYunxia Liu
Yunxia Liu
MLMeina Li
Meina Li
XDXiaoyu Du
Xiaoyu Du
ZHZhehao Huang
Zhehao Huang
NQNanhu Quan
Nanhu Quan

1 September 2020 in Redox Biology
Verified
Journal Article
Open access
NQNanhu Quan
Nanhu Quan
XLXuan Li
Xuan Li
Jingwen ZhangJingwen Zhang
Jingwen Zhang
YHYing Han
Ying Han
WSWeiju Sun
Weiju Sun
Ji LiJi Li
Ji Li
Sestrin2 (Sesn2) is a stress sensor for the mammalian target of rapamycin complex 1 (mTORC1) pathway. Aging impairs cardiac mTORC1 activation, thereby sensitizing the heart to hypertrophy. C57BL/6 J young wild-type (young WT; 4–6 months), aged WT (24–26 months), and young Sestrin2 knockout mice (Y-Sesn2 KO; 4–6 months) underwent transverse aortic constriction (TAC) for pressure overload. Cardiac expression of Sesn2 decreased with age. At 4 weeks after TAC, aged WT and Y-Sesn2 KO exhibited larger hearts and impaired cardiac function, compared with young WT mice. Augmented phosphorylation of mTOR and downstream effectors; damaged mitochondria and elevated redox markers, as well as and impaired glucose and fatty acid oxidation were observed in aged WT and Y-Sesn2 KO hearts. A pressure overload-induced interaction between Sesn2 and GTPase-activating protein activity toward Rags 2 (GATOR2), which positively regulates mTORC1, was impaired in aged WT hearts. Adeno-associated virus 9–Sesn2 treatment rescued Sesn2 expression, attenuated mTORC1 activation, and increased pressure overload tolerance in aged WT and Y-Sesn2 KO hearts. These results indicated that cardiac Sesn2 acts as a pressure overload sensor for mTORC1. Furthermore, Sesn2 deficiency may cause increased sensitivity to hypertrophy in elderly individuals.

1 March 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
YLYunxia Liu
Yunxia Liu
MLMeina Li
Meina Li
MSMeihua Sun
Meihua Sun
YZYaoting Zhang
Yaoting Zhang
XLXuan Li
Xuan Li
NQNanhu Quan
Nanhu Quan

16 June 2024 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
QDQi Dong
Qi Dong
GDGaoying Dai
Gaoying Dai
NQNanhu Quan
Nanhu Quan
QTQian Tong
Qian Tong

6 July 2023 in Current Problems in Cardiology
Verified
Journal Article
Closed access
GDGaoying Dai
Gaoying Dai
MLMeina Li
Meina Li
HXHe Xu
He Xu
NQNanhu Quan
Nanhu Quan

14 January 2026 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
ZWZhaoyang Wei
Zhaoyang Wei
ZLZhixiong Li
Zhixiong Li
NQNanhu Quan
Nanhu Quan
Atrial fibrillation (AF) is the most common type of arrhythmia encountered in the clinical setting, and its occurrence is influenced by various factors, particularly aging. Senescence of atrial myocytes plays an important role in the development of AF, although the precise mechanisms underlying this association remain unclear. This review explores the pivotal role of atrial myocyte senescence in AF pathogenesis, moving beyond chronological age. It provides evidence that aging creates a pro-arrhythmic substrate via three interconnected mechanisms: 1) inflammatory activation (mitochondrial ROS, NLRP3, and SASP), 2) dysregulated calcium handling (RyR2 and SERCA2), and 3) cell cycle disruption (p16, p21, and p53). These pathways, compounded by epigenetic changes and SIRT1/mTOR signaling dysregulation, drive the electrical and structural remodeling that triggers and sustains AF. The review highlights promising therapeutic targets such as SIRT1 activators and NLRP3 inhibitors, proposing an integrated “senescence–AF axis” model, while identifying key research gaps in cell-type specificity and clinical translation. This comprehensive review outlines current progress in research in this area and future research directions and provides valuable references for forthcoming studies.